Adam T. Funk graduated from the University of Texas in Austin with a degree in Business Administration. After graduating college in only three years with honors, Adam worked for an Austin law firm specializing in personal injury and product liability. The work experience in Austin helped Adam understand his true calling in life – helping those in need through this nation’s great civil justice system. Soon thereafter, Adam enrolled at the University of Houston Law Center. While in law school, Adam was a member of the Mock Trial Team and the Moot Court Team and competed in numerous tournaments across the nation. On several occasions, Adam was awarded Best Speaker in the tournament. In addition, Adam was also awarded the Order of the Barristers by the Law School – a rarely-given honor bestowed upon students who have excelled in trial advocacy.
Adam has always been a trial lawyer. Soon after graduating from Law School, Adam immediately went to work at a prestigious firm representing the injured. Adam represented those injured by negligent drivers, by medical professionals, and by huge pharmaceutical corporations. Adam obtained favorable outcomes in trial verdicts and settlements and in his first few years out of law school. His experience led him to be named a Rising Star by Texas Super Lawyers (a Thomson Reuters service) in 2012, 2013, 2017, and 2018.
In 2011, Adam expanded his client base to include Texas and New Mexico. He became an expert in the laws of both states. He spent half his time in Texas and the other half in New Mexico. Throughout his legal career, Adam has only represented those who were personally injured.
Adam has represented thousands of clients who have been injured. Whether he tried their case to a jury or reached a settlement, each client was met with respect, transparency, and honesty. Due to confidential settlement provisions, attorney-client privileges, and Rules of Professional Conduct, Adam cannot specifically list his successes but refers you to his numerous positive client reviews on various websites.
Adam has practiced in 27 different states, 24 federal courts, and has even appeared at the U.S. Supreme Court. He has handled cases involving medical malpractice, car accidents, pharmaceutical products, medical devices, oilfield accidents, birth injuries, and more. Adam’s cases have ranged from leading the fight on behalf of 3,500 clients injured by the pharmaceutical drug Reglan® in Philadelphia Common Pleas Court to trying a case in front of a New Mexico jury on behalf of a widow who lost his spouse due to medical malpractice, and many, many cases in between.
Adam’s greatest joy is fighting zealously for his clients to obtain a favorable result in their case.
In his spare time, Adam enjoys spending time with his wife and two young daughters, reading, running, and tracking the success of Lobos football and Houston Rockets basketball.
- J.D., University of Houston
- B.B.A., University of Texas at Austin
- State Bar of Texas
- State Bar of New Mexico
- U.S. District Court of Southern District of Texas
- U.S. District Court of Northern District of Texas
- U.S. District Court of Western District of Texas
- U.S. District Court of New Mexico
- U.S. District Court of Nebraska
- Super Lawyers® Rising Stars (A Thomson Reuters service), 2011-2013, 2017-2018
- The National Trial Lawyers Top 40 Under 40, Recipient
- National Academy of Jurisprudence, Premier 100 Trial Attorney Nomination
- Avvo.com 10.0 Ratings – Personal Injury, Wrongful Death, and Defective Products
- Houston Business Journal, Top 40 under 40 Nomination
- National Academy of Personal Injury Attorneys, Top 10 Attorney Award Nomination
- American Academy of Trial Attorneys, Premier 100 Trial Attorney Nomination
- National League of Renowned Attorneys, Top One Percent Nomination
- Houstonia Top Lawyers, 2014
Adam has been involved in an impressive number of proceedings involving pharmaceutical or medical device litigation. The list of these proceedings can be found below.
*In re: Seroquel Products Liability Litigation, MDL 1769, United States District Court Middle District of Florida Orlando Division
*In re: Vioxx Products Liability Litigation, MDL NO. 1657, United States District Court, E.D. Louisiana.
*In re: Gadolinium–Based Contrast Agents. Products Liability Litigation, MDL No. 1909, Northern District Court of Ohio
In re: Bextra and Celebrex Marketing Sales Practices and Product Liability Litigation, MDL No. 1699, U.S. District Court for the Northern District of California
*In re: Reglan/Metoclopramide Litigation, Pennsylvania Court of Common Pleas,Philadelphia County
*In re: Reglan Litigation, Case No. 289, Superior Court of New Jersey, Atlantic County.
*Lawrence v. Medtronic, Inc., et al., Hennepin County District Court, Minnesota (Consolidated Infuse Litigation in Minnesota)
*In Re: Biomet M2A Magnum Hip Implant Products Liability Litigation, MDL 2391, United States District Court for the Northern District of Indiana
In Re: Wright Medical Technology, Inc., CONSERVE® Hip Implant Products Liability Litigation, MDL No. 2329, United States District Court for the Northern District of Georgia
In re: DePuy Orthopaedics Inc., ASR™ Hip Implant Products Liability Litigation, MDL 2197, Northern District of Ohio
*In re: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation, MDL No. 2244, Northern district of Texas
*In re Bard IVC Filters Products Liability Litigation, MDL No. 2641, United States District Court for the District of Arizona
*In re Cook Medical, Inc, IVC Filters Marketing, Sales Practices and Products Liability Litigation, MDL No. 2570, United States District Court for the Southern District of Indiana
In re: Testosterone Replacement Therapy Products Liability Litigation, MDL No. 1748, U.S. District Court for the Northern District of Illinois
*In re Avandia Marketing, Sales Practices and Products Liability Litigation, MDL No. 1871, U.S. District Court for the Eastern District of Pennsylvania,
* Denotes a proceeding in which Adam was involved in leadership, discovery, depositions, oral arguments, motion practice, and/or settlement discussions.